Treatment outcomes of pulmonary TB in adults in Indonesia
IJTLD Open · 2025-03 · 2 (3) · 145-152
DOI: 10.5588/ijtldopen.24.0482 ↗Kurz gefasst
Fachartikel in der Zeitschrift IJTLD Open, online erschienen am 01.03.2025. Verfasst von R I Sugiyono und 18 weiteren Autor:innen. Beteiligte Einrichtung: Indonesia Research Partnership on Infectious Diseases (INA-RESPOND), Jakarta, Indonesia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND Achieving the goal of Ending TB requires a treatment success rate of ≥90%, a challenging target for Indonesia. To understand outcomes and associated factors for unfavourable outcomes, we analysed prospective multicentre study data from 2017 to 2020 involving drug-susceptible TB (DS-TB) and multidrug-resistant TB (MDR-TB) treatment adult patients. METHODS This study focused on bacteriologically confirmed participants based on Xpert MTB/RIF or culture results. We analysed participants with available treatment outcomes — cured, completed, failed, dead, and lost to follow-up (LTFU) — excluding withdrawn or transferred. Univariable and multivariable logistic regression analyses identified factors associated with unfavourable outcomes. RESULTS Among 328 bacteriologically confirmed participants with available outcomes, the overall treatment success was 72.3% (DS-TB: 81.6% and MDR-TB: 60.1%). Unfavourable outcomes were 27.7%, with 3.6% failures, 9.5% deaths, and 14.6% LTFUs. Associated factors for unfavourable outcomes included age ≥50 years (aOR 2.54, 95% CI 1.11–5.95; P = 0.029); being underweight (aOR 1.93, 95% CI 1.05–3.61; P = 0.037); having baseline acid-fast bacilli smear of scanty/+1 (aOR 3.77, 95% CI 1.41–11.65; P = 0.013) or +2/+3 (aOR 3.34, 95% CI 1.31–9.83; P = 0.017); and being treated with MDR-TB regimen (aOR 2.03, 95% CI 1.05–3.96; P = 0.036). CONCLUSION Strategies to improve outcomes include tailored care for older adults, nutritional support, treatment monitoring, and enhanced MDR-TB management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Indonesia Research Partnership on Infectious Diseases (INA-RESPOND), Jakarta, Indonesia.
- Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia, Persahabatan Hospital, Jakarta, Indonesia.
- Department of Microbiology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
- Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Hospital, Surabaya, Indonesia.
- Division Pulmonology and Critical Care, Department of Internal Medicine, Kariadi Hospital, Semarang, Indonesia.
- Division of Pulmonology, Department of Internal Medicine Sardjito Hospital, Yogyakarta, Indonesia.
Zitieren
APA
Sugiyono, R. I., Naysilla, A. M., Susanto, N. H., Handayani, D., Burhan, E., Karuniawati, A., Kusmiati, T., Wibisono, B. H., Riyanto, B. S., Sajinadiyasa, I. G. K., Djaharuddin, I., Sinaga, B. Y. M., Dewantara, R. D., Karyana, M., Kosasih, H., Liang, C. J., Ridzon, R., Neal, A. T., & Chen, R. Y. (2025). Treatment outcomes of pulmonary TB in adults in Indonesia. IJTLD Open, 2(3), 145-152. https://doi.org/10.5588/ijtldopen.24.0482
Vancouver
Sugiyono RI, Naysilla AM, Susanto NH, Handayani D, Burhan E, Karuniawati A, et al. Treatment outcomes of pulmonary TB in adults in Indonesia. IJTLD Open. 2025;2(3):145-152. doi:10.5588/ijtldopen.24.0482
BibTeX
@article{Sugiyono2025,
author = {Sugiyono, R I and Naysilla, A M and Susanto, N H and Handayani, D and Burhan, E and Karuniawati, A and Kusmiati, T and Wibisono, B H and Riyanto, B S and Sajinadiyasa, I G K and Djaharuddin, I and Sinaga, B Y M and Dewantara, R D and Karyana, M and Kosasih, H and Liang, C J and Ridzon, R and Neal, A T and Chen, R Y},
title = {Treatment outcomes of pulmonary TB in adults in Indonesia},
journal = {IJTLD Open},
year = {2025},
volume = {2},
number = {3},
pages = {145--152},
doi = {10.5588/ijtldopen.24.0482}
}
EUVIMED